| Dr Stefanie Plant, PHARMD | |
|
1054 Cass Ave, Woonsocket, RI 02895-4935 | |
| (401) 767-3600 | |
| Not Available |
| Full Name | Dr Stefanie Plant |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1054 Cass Ave, Woonsocket, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295322196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH05027 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stefanie Plant, PHARMD 12 Frances St, Cumberland, RI 02864-7602 Ph: (401) 374-2151 | Dr Stefanie Plant, PHARMD 1054 Cass Ave, Woonsocket, RI 02895-4935 Ph: (401) 767-3600 |
News Archive
A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anti-cancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.
E. Fougera & Co., a leading specialty pharmaceutical manufacturer, today announced it has received first generic approval from the FDA for Imiquimod Cream 5% (Rx). Fougera's Imiquimod Cream 5% is rated AB, generically equivalent to Aldara® by Graceway Pharmaceuticals and substitutable for all indications. According to industry data, U.S. sales of the brand named product in 2009 exceed $360 million.
Young cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study to be presented at the ESMO 2018 Congress in Munich, has highlighted the existence of barriers to the inclusion of 12 to 25-year-olds in both adult and pediatric early phase clinical trials, suggesting a need for more tailored approaches to give this patient population better access to therapeutic innovation.
Every year, tens of millions of individuals across Europe undergo endoscopic procedures to assist with the diagnosis and management of gastrointestinal diseases.
In a discovery with implications for future drug design, scientists from the Florida campus of The Scripps Research Institute have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
› Verified 9 days ago
Pamela Ann Palermo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Social St, Woonsocket, RI 02895 Phone: 401-762-9200 | |
Ms. Christine C Sawicki, RPH, MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Cvs Dr, Woonsocket, RI 02895 Phone: 401-765-1500 Fax: 401-652-9074 | |
Thuymai Kathy Ung, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Cvs Dr # 288, Woonsocket, RI 02895 Phone: 424-522-2760 | |
Mr. Michael D Sherry, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Cvs Dr, Woonsocket, RI 02895 Phone: 401-770-5983 | |
Dr. Brittany Handschiegl, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Cvs Dr, Woonsocket, RI 02895 Phone: 617-470-3065 | |
Ali Abdulmajeed, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Cvs Dr, Woonsocket, RI 02895 Phone: 401-765-1500 | |
Dr. David Russell Talbert, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Cvs Dr, Woonsocket, RI 02895 Phone: 919-554-1900 |